Clinical Trials Browser

Interventional × Thyroid Neoplasms × apatinib × Clear all

NCT02731352 2022-01-20

Study of Apatinib in Patients With Differentiated Thyroid Cancer

Phase 2 Completed

Thyroid Neoplasms

NCT04612894 2020-11-03

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Phase 2 Unknown

Thyroid Neoplasms

NCT03300765 2017-10-03

Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer

Phase 2 Unknown

Thyroid Neoplasms